Literature DB >> 7814145

Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.

D J Easty1, M Herlyn, D C Bennett.   

Abstract

Protein tyrosine kinases have been implicated in tumor initiation and progression. Here we used Northern blotting to study expression of their genes in cultured normal melanocytes and 19 melanoma cell lines from different stages of tumor progression. We detected transcripts for 2 cytoplasmic (ABL and FES) and 6 receptor (ECK, ERB-B2, FGF-R4, IGFI-R, KDR and TIE) kinases but not for receptors RET or TRK-A. Genes for ECK, FGF-R4 and TIE were expressed ectopically in melanomas (not in normal melanocytes). Similarly, ECK protein was detected by immunoblotting in metastatic melanomas but not in normal melanocytes. ECK mRNA levels tended to increase again during late melanoma progression. ECK and TIE mRNAs were also detected in highly metastatic variant cells but not in the corresponding poorly metastatic parental lines. Conversely, FES and KDR gene expression was lost in most advanced primary and metastatic melanomas. These findings suggest positive and negative roles for specific tyrosine kinases during progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814145     DOI: 10.1002/ijc.2910600119

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

Review 1.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

Review 2.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

3.  Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.

Authors:  H Iida; M Honda; H F Kawai; T Yamashita; Y Shirota; B-C Wang; H Miao; S Kaneko
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 4.  Vasculogenic mimicry and tumor angiogenesis.

Authors:  R Folberg; M J Hendrix; A J Maniotis
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.

Authors:  Michael Olvedy; Julie C Tisserand; Flavie Luciani; Bram Boeckx; Jasper Wouters; Sophie Lopez; Florian Rambow; Sara Aibar; Bernard Thienpont; Jasmine Barra; Corinna Köhler; Enrico Radaelli; Sophie Tartare-Deckert; Stein Aerts; Patrice Dubreuil; Joost J van den Oord; Diether Lambrechts; Paulo De Sepulveda; Jean-Christophe Marine
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

Review 6.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

7.  c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines.

Authors:  Yuichiro Ohshima; Ichiro Yajima; Kozue Takeda; Machiko Iida; Mayuko Kumasaka; Yoshinari Matsumoto; Masashi Kato
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

8.  High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.

Authors:  Guangyuan Zeng; Zhiqiang Hu; Michael S Kinch; Chong-Xian Pan; David A Flockhart; Chinghai Kao; Thomas A Gardner; Shaobo Zhang; Lang Li; Lee Ann Baldridge; Michael O Koch; Thomas M Ulbright; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

9.  EphA2 as a promoter of melanoma tumorigenicity.

Authors:  Naira V Margaryan; Luigi Strizzi; Daniel E Abbott; Elisabeth A Seftor; M Sambasiva Rao; Mary J C Hendrix; Angela R Hess
Journal:  Cancer Biol Ther       Date:  2009-02-21       Impact factor: 4.742

10.  Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.

Authors:  Miao Huang; Chiyi Xiong; Wei Lu; Rui Zhang; Min Zhou; Qian Huang; Jeffrey Weinberg; Chun Li
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.